Evidence Hub

A Rare Case of Metformin-Induced Lactic Acidosis and Concomitant Euglycemic Ketoacidosis

Shiplett A, Mathias J

Cureus, 2024

Abstract

Acidemia arises primarily from the accumulation of carbon dioxide or the loss of bicarbonate, leading to a pH decrease within the body, which can be fatal if severe and not promptly addressed. Metabolic acidemia occurs due to a loss of bicarbonate and can manifest through direct losses of bicarbonate via renal or gastrointestinal routes, or through the accumulation of anions such as lactic acid or ketoacids, leading to an anion gap metabolic acidosis. Many common etiologies for lactic acid and ketoacid generation exist, including medication-induced causes. Metformin-induced lactic acidemia is a well-known, yet rare, complication of metformin usage, but metformin-induced ketoacidemia is not well described. This report presents a case involving a patient with end-stage renal disease (ESRD) who, while taking metformin, developed severe anion gap metabolic acidosis with undetectably high levels of lactic acid and ketones, supporting the potential role of metformin in inducing severe lactic acidosis and ketoacidosis.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free